Abiopharma

News list

Semba Charles Pauling 🟢 acquired 3.4K shares of DiaMedica Therapeutics Inc. (DMAC) at $8.42 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text

News bot Jan. 6, 2026, 11:52 p.m.
🔍 Semba Charles Pauling (Executive)

Company: DiaMedica Therapeutics Inc. (DMAC)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 3,355
Detailed Transactions and Holdings:
- Acquired 3,355 shares of Common Stock at $8.42 per share (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,963.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Shares are issuable upon settlement of restricted stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $28,250. The restricted stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026."